Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allon, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allon, M.

Journal of the American Society of Nephrology, Vol 6, 1134-1142, Copyright © 1995 by American Society of Nephrology

REVIEWS

Hyperkalemia in end-stage renal disease: mechanisms and management

M Allon

Clinical investigations in the past few years have enhanced the understanding of the mechanisms of hyperkalemia in patients with ESRD. The results of these studies have led to modifications in the acute treatment and prevention of hyperkalemia in this patient population. They have confirmed the efficacy of intravenous insulin, while raising doubts about the utility of intravenous bicarbonate, for the acute treatment of hyperkalemia. Moreover, the beta-adrenergic agonist albuterol has been shown to be a useful adjunct to insulin for acutely lowering plasma potassium. Finally, there has been enhanced recognition of nondietary factors that can predispose to hyperkalemia in patients with ESRD, including prolonged fasting and the use of nonselective beta- adrenergic blockers. These new insights may improve the clinical management of hyperkalemia in patients with renal failure.


This article has been cited by other articles:


Home page
 Journal of Pharmacy PracticeHome page
J. Hawboldt and D. McGrath
Possible Metoprolol-Induced Hyperkalemia
Journal of Pharmacy Practice, October 1, 2006; 19(5): 320 - 325.
[Abstract] [PDF]

Home page
 CirculationHome page
Part 10.1: Life-Threatening Electrolyte Abnormalities
Circulation, December 13, 2005; 112(24_suppl): IV-121 - IV-125.
[Full Text] [PDF]

Home page
 J. Am. Podiatr. Med. Assoc.Home page
J. Costa, R. S. Crausman, and M. S. Weinberg
Acute and Chronic Renal Failure
J Am Podiatr Med Assoc, March 1, 2004; 94(2): 168 - 176.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
C. G. Acker, J. P. Johnson, P. M. Palevsky, and A. Greenberg
Hyperkalemia in Hospitalized Patients: Causes, Adequacy of Treatment, and Results of an Attempt to Improve Physician Compliance With Published Therapy Guidelines
Arch Intern Med, April 27, 1998; 158(8): 917 - 924.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673